Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

Clinical trial NCT00654030 · COMPLETED

Trial details

NCT number: NCT00654030
Sponsor: Edward Hirschowitz
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2006-10-01
Primary completion: 2009-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.